Obese and overweight patients clamouring for Novo Nordisk’s weight-loss and diabetes drugs have helped the Danish drugmaker grow into Europe’s largest company. Now, it wants to go a step further and stop people gaining weight in the first place.
肥胖和超重患者對諾和諾德(Novo Nordisk)減肥和糖尿病藥物的強烈需求，幫助這家丹麥製藥商成長爲歐洲最大的公司。現在，它想更進一步，從一開始就阻止人們發胖。
您已閱讀3%（329字），剩餘97%（10313字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。